Abstract
BackgroundTreatment with tumor necrosis factor inhibitors (TNFi) such as etanercept (ETN) is effective in patients with rheumatoid arthritis (RA). However, not all patients respond to treatment. Physicians would be able...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have